Received Aug 11, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RVX | ROTAVIRUS (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
I have breathing problems since the RSV vaccine; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of difficulty breathing in a patient who received RSVPreF3 adjuvanted (RSV vaccine) for prophylaxis. On an unknown date, the patient received RSV vaccine. On an unknown date, an unknown time after receiving RSV vaccine, the patient experienced difficulty breathing (Verbatim: I have breathing problems since the RSV vaccine). The outcome of the difficulty breathing was not reported. It was unknown if the reporter considered the difficulty breathing to be related to RSV vaccine. It was unknown if the company considered the difficulty breathing to be related to RSV vaccine. Additional Information: GSK Receipt Date: 01-AUG-2025 This case was received by the patient via interactive digital media. Reporter reported that he/she had breathing problems since the RSV vaccine. Reporter wish that he/she had not gotten it.